JP6278960B2 - 非病原性ｆ１８ｅ．ｃｏｌｉ株及びその使用 - Google Patents

非病原性ｆ１８ｅ．ｃｏｌｉ株及びその使用 Download PDF

Info

Publication number
JP6278960B2
JP6278960B2 JP2015521918A JP2015521918A JP6278960B2 JP 6278960 B2 JP6278960 B2 JP 6278960B2 JP 2015521918 A JP2015521918 A JP 2015521918A JP 2015521918 A JP2015521918 A JP 2015521918A JP 6278960 B2 JP6278960 B2 JP 6278960B2
Authority
JP
Japan
Prior art keywords
composition
strain
coli
pathogenic
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015521918A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015525566A (ja
JP2015525566A5 (https=
Inventor
モリス フェアブラザー、ジョン
モリス フェアブラザー、ジョン
ナデュー、エリック
デソーテルズ、クラリッセ
Original Assignee
プレヴテック マイクロビア インコーポレイテッド
プレヴテック マイクロビア インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プレヴテック マイクロビア インコーポレイテッド, プレヴテック マイクロビア インコーポレイテッド filed Critical プレヴテック マイクロビア インコーポレイテッド
Publication of JP2015525566A publication Critical patent/JP2015525566A/ja
Publication of JP2015525566A5 publication Critical patent/JP2015525566A5/ja
Application granted granted Critical
Publication of JP6278960B2 publication Critical patent/JP6278960B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2015521918A 2012-07-20 2013-07-18 非病原性ｆ１８ｅ．ｃｏｌｉ株及びその使用 Active JP6278960B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261674179P 2012-07-20 2012-07-20
US61/674,179 2012-07-20
PCT/CA2013/000660 WO2014012172A1 (en) 2012-07-20 2013-07-18 Non-pathogenic f18 e. coli strain and use thereof

Publications (3)

Publication Number Publication Date
JP2015525566A JP2015525566A (ja) 2015-09-07
JP2015525566A5 JP2015525566A5 (https=) 2016-09-08
JP6278960B2 true JP6278960B2 (ja) 2018-02-14

Family

ID=49948133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015521918A Active JP6278960B2 (ja) 2012-07-20 2013-07-18 非病原性ｆ１８ｅ．ｃｏｌｉ株及びその使用

Country Status (17)

Country Link
US (3) US9453195B2 (https=)
EP (1) EP2875121B1 (https=)
JP (1) JP6278960B2 (https=)
KR (1) KR102171028B1 (https=)
CN (1) CN104736695B (https=)
BR (1) BR112015001175B1 (https=)
CA (1) CA2879155C (https=)
DK (1) DK2875121T3 (https=)
ES (1) ES2663019T3 (https=)
HU (1) HUE036545T2 (https=)
MX (1) MX363057B (https=)
PH (1) PH12015500091A1 (https=)
PL (1) PL2875121T3 (https=)
PT (1) PT2875121T (https=)
RS (1) RS57056B1 (https=)
RU (1) RU2670882C9 (https=)
WO (1) WO2014012172A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112015001175B1 (pt) 2012-07-20 2022-03-03 Elanco Canada Limited Composição compreendendo uma cepa de e.coli isolada e usos da mesma
KR102567744B1 (ko) * 2015-02-11 2023-08-18 에바 뉴트리션 인크 생존 가능한 대장균을 삽입하기 위한 향상된 건조 기질, 이의 제조 방법 및 용도
KR101715625B1 (ko) * 2015-06-02 2017-03-13 대한민국(농림축산식품부 농림축산검역본부장) 부종병 독소를 생산하는 대장균, 이를 이용한 부종병 독소의 생산방법 및 이를 포함하는 돼지 부종병 예방용 백신 조성물
CA3027896C (en) * 2016-06-14 2021-07-13 Prevtec Microbia Inc. Animal feed pellets including a feed additive, method of making and of using same
EP3648769A4 (en) * 2017-06-30 2021-04-07 The Rockefeller University HUMAN INTESTINAL FLORA-DERIVED N-ACYLAMIDES FOR THE TREATMENT OF HUMAN DISEASES
CN107523529B (zh) * 2017-10-20 2021-03-12 林州中农颖泰生物肽有限公司 一种利用大肠杆菌生产肠杆菌肽的工艺及其应用
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
CN109628361B (zh) * 2018-11-27 2022-08-19 扬州大学 整合双拷贝功能性f4菌毛操纵子基因猪源益生菌ep1克隆株、构建方法及应用
CN114752531B (zh) * 2022-04-29 2023-05-26 扬州大学 一株同时表达f4和f18菌毛的猪源大肠杆菌无毒分离株及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125455C1 (ru) * 1996-09-25 1999-01-27 Саратовская научно-исследовательская ветеринарная станция Способ профилактики диареи молодняка сельскохозяйственных животных
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
WO2000006764A1 (en) * 1998-07-30 2000-02-10 Wisconsin Alumni Research Foundation Gastrointestinal bacterial antibody factories
US6304216B1 (en) 1999-03-30 2001-10-16 Conexant Systems, Inc. Signal detector employing correlation analysis of non-uniform and disjoint sample segments
HU221664B1 (hu) * 1999-03-31 2002-12-28 MTA Állatorvostudományi Kutatóintézete Élő, szájon át adható Escherichia coli vakcina készítésére alkalmas törzs a sertések választási hasmenésének megelőzésére és a törzs előállítására alkalmas eljárás
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
BR0116178A (pt) 2000-11-30 2003-10-14 Bio Balance Corp Cepa bacterial, composição probiótica compreendendo uma cepa bacterial, formulação compreendendo pelo menos uma fração volátil de um extrato de planta, aditivo alimentar, processo de preparação de uma fração volátil de uma planta, processo de preparação de uma formulação terapêutica, processo de crescimento de uma cepa bacterial, processo de manufatura de uma composição probiótica, processo de preparo de uma composição probiótica, processo de preparo de uma composição incluindo microorganismos viáveis, dispensador de microorganismo, método de bio controle de um organismo, método para eliminar uma poluição de óleo, método de recuperação de fumaças org‰nicas, produto alimentar e método de preparo inicial para um processo de fermantação
KR101148255B1 (ko) 2002-10-04 2012-08-08 다니스코 유에스 인크. 고수율을 갖는 1,3-프로판디올의 생물학적 제조 방법
HUE024565T2 (hu) * 2004-02-03 2016-02-29 Prevtec Microbia Inc Élõ baktériumok alkalmazása növekedésserkentésre állatokban
CA2566617C (en) * 2004-05-14 2013-12-31 Agtech Products, Inc. Method and composition for reducing e.coli disease and enhancing performance using bacillus
US7927586B2 (en) * 2008-07-08 2011-04-19 South Dakota State University Vaccine for porcine post-weaning diarrhea caused by enterotoxigenic Escherichia coli
BR112015001175B1 (pt) 2012-07-20 2022-03-03 Elanco Canada Limited Composição compreendendo uma cepa de e.coli isolada e usos da mesma

Also Published As

Publication number Publication date
CA2879155A1 (en) 2014-01-23
US10258654B2 (en) 2019-04-16
ES2663019T3 (es) 2018-04-10
JP2015525566A (ja) 2015-09-07
US20150152377A1 (en) 2015-06-04
RU2670882C9 (ru) 2018-12-11
CA2879155C (en) 2024-04-30
KR20150036698A (ko) 2015-04-07
HUE036545T2 (hu) 2018-07-30
RU2015105738A (ru) 2016-09-10
BR112015001175B1 (pt) 2022-03-03
US20160361369A1 (en) 2016-12-15
US20180008651A1 (en) 2018-01-11
EP2875121A4 (en) 2016-01-13
DK2875121T3 (en) 2018-04-16
US9775867B2 (en) 2017-10-03
PL2875121T3 (pl) 2018-06-29
CN104736695B (zh) 2017-05-24
EP2875121B1 (en) 2018-01-03
EP2875121A1 (en) 2015-05-27
BR112015001175A2 (pt) 2017-06-27
PH12015500091B1 (en) 2015-03-02
PH12015500091A1 (en) 2015-03-02
WO2014012172A1 (en) 2014-01-23
RU2670882C2 (ru) 2018-10-25
US9453195B2 (en) 2016-09-27
KR102171028B1 (ko) 2020-10-28
PT2875121T (pt) 2018-03-14
MX2015000905A (es) 2015-09-28
CN104736695A (zh) 2015-06-24
MX363057B (es) 2019-03-06
HK1209780A1 (en) 2016-04-08
RS57056B1 (sr) 2018-05-31

Similar Documents

Publication Publication Date Title
JP6278960B2 (ja) 非病原性ｆ１８ｅ．ｃｏｌｉ株及びその使用
Fuller Probiotics 2: applications and practical aspects
Barrow Probiotics for chickens
Zhang et al. Effect of a potential probiotics Lactococcus garvieae B301 on the growth performance, immune parameters and caecum microflora of broiler chickens
Herich et al. Effect of preventive application of Enterococcus faecium EF55 on intestinal mucosa during salmonellosis in chickens
Unterweger et al. Administration of non-pathogenic isolates of Escherichia coli and Clostridium perfringens type A to piglets in a herd affected with a high incidence of neonatal diarrhoea
Frederic et al. Application of high energy and protein diets in combination with a live avirulent Escherichia coli F4 vaccine against post-weaning diarrhea
US8673290B2 (en) Sporulation-deficient B. texasporus cells and methods for efficient and cost-effective inactivation and use thereof
Castañeda Bustillo Early administration of probiotics through in ovo inoculation and their impact on gut microflora, immune response, and growth performance of broiler chicks
HK1209780B (en) Non-pathogenic f18 e. coli strain and use thereof
US20240277788A1 (en) Compositions for increasing resilience towards bacterial infections
Bustillo Early Administration of Probiotics through in Ovo Inoculation and Their Impact on Gut Microflora, Immune Response, and Growth Performance of Broiler Chicks
Hur et al. Age-dependent competition of porcine enterotoxigenic E. coli (ETEC) with different fimbria genes
Nhi et al. SWINE COLIBACILLOSIS IN PIG
Rattanatabtimtong Effects of Egg Yolk Antibodies on Weanling Pigs Challenged with Pathogenic Salmonella Typhimurium
Sudheendra et al. Potential Application of Probiotics for Human Health Benefits
Yang Feed fermentation formulate gut microbiota of weanling pigs-Effects of exopolysaccharides and reutericyclin
Kantas et al. A feed additive containing Bacillus toyonensis in weaning piglets

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20150629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160719

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160719

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170509

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170808

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20171219

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180116

R150 Certificate of patent or registration of utility model

Ref document number: 6278960

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250